Cluster headache with obstructive sleep apnea and periodic limb movements during sleep: a case report.

abstract：:A parallel, randomized, double-blind trial is reported, in which 78 patients with chronic tension-type headaches were treated with L-5-hydroxytryptophan (5-HTP) (n = 43) or placebo (n = 35) for 8 weeks, after a washout period of 2 weeks and with a follow-up period of a further 2 weeks. Five patients dropped out (1 wit...

journal_title：Headache

authors： Ribeiro CA

更新日期：2000-06-01 00:00:00

abstract：:Seven SUNCT patients (six men, one woman) took part in this study. In four patients, respiratory variables were compared during and outside attacks. In five patients, peripheral chemosensitivity was tested and compared with a control group matched with respect to age, sex, and smoking habits. The results indicate that...

journal_title：Headache

authors： Kruszewski P,White LR,Shen JM,Pareja JA,Zhao JM,Schaanning J,Sjaastad O

更新日期：1995-06-01 00:00:00

abstract：:Observations including the long-recognized tendency of migraine to run in families, the high concordance rates for migraine in twins reared together or apart, and the association of specific mutations with a rare migraine form are consistent with a genetic contribution to the disorder. This paper summarizes major find...

journal_title：Headache

authors： Gardner KL

更新日期：2006-06-01 00:00:00

abstract：OBJECTIVE:To compare the efficacy of celecoxib for treatment of withdrawal headache vs prednisone in patients with medication overuse headache (MOH). METHODS:In this prospective, double-blind, parallel-group clinical trial, 97 consecutive subjects with MOH were randomized (simple randomization using computer-generated...

journal_title：Headache

authors： Taghdiri F,Togha M,Razeghi Jahromi S,Paknejad SM

更新日期：2015-01-01 00:00:00

abstract：BACKGROUND:Whereas the clinical features of pure triptan overuse headache (TOH) are well known, there are insufficient data regarding the semiological pattern of headaches when triptan overuse is associated with other types of medication overuse. OBJECTIVE:To investigate and compare the clinical characteristics of pat...

journal_title：Headache

authors： Créac'h C,Radat F,Mick G,Guegan-Massardier E,Giraud P,Guy N,Fabre N,Nachit-Ouinekh F,Lanteri-Minet M

更新日期：2009-04-01 00:00:00

abstract：:The aim of the study was to compare adult migraine discordant full siblings in terms of personality and psychosocial environment during childhood. The study, involving 30 sibling pairs and use of various personality instruments (Eysenck Personality Inventory [EPI], Color Word Test [CWT], Visual Aftereffects [VAE], Met...

journal_title：Headache

authors： Persson B

更新日期：1997-03-01 00:00:00

abstract：BACKGROUND:Eletriptan is a potent 5-HT(1B/1D) agonist with proven efficacy in the acute treatment of migraine in adults. OBJECTIVE:To evaluate the efficacy and tolerability of eletriptan 40 mg versus placebo in adolescent patients (aged 12-17). METHODS:A multicenter, double-blind, parallel-group, placebo-controlled t...

journal_title：Headache

authors： Winner P,Linder SL,Lipton RB,Almas M,Parsons B,Pitman V

更新日期：2007-04-01 00:00:00

abstract：BACKGROUND:Persistent migraine aura without infarction (PMA) is a rare condition that is defined as an aura that lasts longer than 1 week in absence of infarction. Two types of PMA have been distinguished, notably persistent primary visual disturbance (PPVD) and typical aura (TA). OBJECTIVES:This case-based review art...

journal_title：Headache

authors： Thissen S,Vos IG,Schreuder TH,Schreurs WM,Postma LA,Koehler PJ

更新日期：2014-09-01 00:00:00

abstract：OBJECTIVE:To evaluate the association between a serotonin (5-HT) transporter gene polymorphism and migraines in Koreans. BACKGROUND:The 5-HT metabolism is believed to play an important part in the pathophysiology of migraines, and a polymorphism of the serotonin transporter (5-HTT) promoter region might influence 5-HT...

journal_title：Headache

authors： Kim WK,Kim HS,Kim WJ,Lee KY,Park H,Kim CH,Kim SJ,Choi YC

更新日期：2005-09-01 00:00:00

abstract：BACKGROUND:Headache diaries are a mainstay of migraine management. While many commercial smartphone applications (apps) have been developed for people with migraine, little is known about how well these apps protect patient information and whether they are secure to use. OBJECTIVE:We sought to assess whether there are...

journal_title：Headache

authors： Minen MT,Stieglitz EJ,Sciortino R,Torous J

更新日期：2018-07-01 00:00:00

abstract：:To assess the burden of migraine, we compared the productivity and the perceived health of 991 migraine sufferers (IHS criteria), 1,004 other-headache sufferers, and 1,757 nonheadache sufferers randomly chosen among volunteers from employees of the French national gas and electricity company. The extent of absenteeism...

journal_title：Headache

authors： Michel P,Dartigues JF,Lindoulsi A,Henry P

更新日期：1997-02-01 00:00:00

abstract：BACKGROUND AND OBJECTIVES:Certain neuromodulators, most notably topiramate (TPM) and divalproex sodium (DVP), are effective preventive agents for migraine. Published data from head-to-head studies comparing TPM and DVP are not available. The purpose of this study was to compare TPM and DVP for the prophyaxis of migrain...

journal_title：Headache

authors： Krymchantowski AV,Jevoux CC

更新日期：2011-04-01 00:00:00

abstract：:Eighty-eight children and adolescents were prospectively evaluated at eight specialty clinics comparing the diagnostic criteria of the International Headache Society (IHS) and the proposed revised (IHS-R) classification to the clinical diagnosis. The proposed revisions to the IHS classification for pediatric migraine ...

journal_title：Headache

authors： Winner P,Wasiewski W,Gladstein J,Linder S

更新日期：1997-10-01 00:00:00

abstract：OBJECTIVE:Presentation of pooled analysis of safety data for fremanezumab in patients with chronic (CM) or episodic migraine (EM) from 4 placebo-controlled phase 2b and phase 3 studies. BACKGROUND:There is a need for an effective, safe, and well-tolerated preventive therapy that specifically targets the pathophysiolog...

journal_title：Headache

authors： Silberstein SD,McAllister P,Ning X,Faulhaber N,Lang N,Yeung P,Schiemann J,Aycardi E,Cohen JM,Janka L,Yang R

更新日期：2019-06-01 00:00:00

abstract：OBJECTIVE:To compare the efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects. BACKGROUND:Currently, no triptan is approved in the United States for the treatment of migraine in adolescent subjects (12 to 17 years). In a previous ...

journal_title：Headache

authors： Winner P,Rothner AD,Wooten JD,Webster C,Ames M

更新日期：2006-02-01 00:00:00

abstract：:Questions about discomfort or pain produced by various stimuli (e.g., light, sound, exercise, neck movements) are currently used to differentiate between various primary headache disorders. In order to evaluate the usefulness of differences in sensitivity to physical stimuli in headache diagnosis, the answers to a que...

journal_title：Headache

authors： Vingen JV,Sand T,Stovner LJ

更新日期：1999-09-01 00:00:00

abstract：BACKGROUND:A vascular component in ergotamine-induced headache has been proposed. No study has been carried out to evaluate cerebral hemodynamic changes by means of transcranial Doppler during withdrawal from migraine medication; in particular, ergotamine-containing drugs. METHOD:We examined 21 patients suffering from...

journal_title：Headache

authors： Haase CG,Diener HC

更新日期：1998-10-01 00:00:00

abstract：OBJECTIVE:To evaluate the efficacy of ubrogepant on patient-reported functional disability, satisfaction with study medication, and global impression of change. BACKGROUND:Ubrogepant is a small-molecule, oral calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine. In 2 phase ...

journal_title：Headache

authors： Dodick DW,Lipton RB,Ailani J,Halker Singh RB,Shewale AR,Zhao S,Trugman JM,Yu SY,Viswanathan HN

更新日期：2020-04-01 00:00:00

abstract：:The treatment of migraine was transformed in 1992 with the introduction of the first triptan-based therapy, subcutaneous (SC) sumatriptan. SC sumatriptan has high efficacy and a rapid onset of action compared with other available triptans and formulations presumably because of its short Tmax, high Cmax, and avoidance ...

journal_title：Headache

authors： Rothrock JF,Freitag FG,Farr SJ,Smith EF 3rd

更新日期：2013-09-01 00:00:00

abstract：BACKGROUND:Migraine is a highly prevalent disorder that imposes an important burden of disability to patients and has social and economic impact in developed countries. A good screening tool for migraine diagnosis is useful to improve disease identification and therapeutic approaches, hopefully reducing the burden of m...

journal_title：Headache

authors： Gil-Gouveia R,Martins I

更新日期：2010-03-01 00:00:00

abstract：:Three decades of research has produced effective behavioral treatments for migraine and tension-type headache, yet the full fruition of this research has not been realized. Further development and dissemination of behavioral treatments is needed to impact the large numbers of those with headache who potentially could ...

journal_title：Headache

authors： Penzien DB,Rains JC,Lipchik GL,Nicholson RA,Lake AE 3rd,Hursey KG

更新日期：2005-05-01 00:00:00

abstract：:Nasal signs and symptoms commonly accompany cephalgia in some headache syndromes. Head pain associated with sinusitis is also fairly well-recognized. However, referred cephalgia of rhinogenic origin, in the absence of sinonasal symptoms or disease, is poorly understood. We report a case of a patient with chronic and s...

journal_title：Headache

authors： Clerico DM,Fieldman R

更新日期：1994-04-01 00:00:00

abstract：:In order to evaluate the effect of non-pharmacological treatment on menstrual and non-menstrual migraine headache (HA), 2 studies have been conducted. In Study 1 which was a retrospective examination of between group reactions to non-drug treatments, 37 self-defined menstrual migraineurs and 62 non-menstrual migraineu...

journal_title：Headache

authors： Kim M,Blanchard EB

更新日期：1992-04-01 00:00:00

abstract：:Discrimination toward people living with migraine and other headache disorders is widespread and socially accepted. Stigma toward these diseases is both a manifestation of these discriminatory attitudes and a sustainer of them. For those living with migraine and headache disorders, stigma limits the full expression of...

journal_title：Headache

authors： Shapiro RE

更新日期：2020-10-01 00:00:00

abstract：BACKGROUND:Borderline personality disorder (BPD) may be disproportionately common in the migraine patient population, but specific migraine features in the BPD subgroup remain incompletely characterized. PURPOSE:To define more clearly the clinical characteristics of migraine patients with BPD, to evaluate their clinic...

journal_title：Headache

authors： Rothrock J,Lopez I,Zweilfer R,Andress-Rothrock D,Drinkard R,Walters N

更新日期：2007-01-01 00:00:00

abstract：:A serologically proven case of parainfluenza viral infection was associated with the onset and disappearance of cluster headache. The patient had long-standing migraine that ceased during the cluster headache period and recurred when the latter stopped. Possibly, the virus was neurally transmitted to the trigeminal-au...

journal_title：Headache

authors： Blanchard BM

更新日期：1998-02-01 00:00:00

abstract：BACKGROUND:Headache is commonly voiced by adolescents and is known to be associated with reduced quality of life. Otherwise, there are only limited data regarding associations between different types of headache and psychopathological symptoms in adolescents. OBJECTIVES:Aim of the present study in adolescents was to a...

journal_title：Headache

authors： Milde-Busch A,Boneberger A,Heinrich S,Thomas S,Kühnlein A,Radon K,Straube A,von Kries R

更新日期：2010-05-01 00:00:00

abstract：:Ischemic colitis has not been reported in association with naratriptan therapy. We describe the occurrence of ischemic colitis in a patient who was treated with abortive doses of naratriptan for migraine and was also taking long-term oral contraceptives. Concurrent use of naratriptan and oral contraceptives should pro...

journal_title：Headache

authors： Charles JA,Pullicino PM,Stoopack PM,Shroff Y

更新日期：2005-04-01 00:00:00

abstract：:Several second-generation triptans have been introduced that differ in their pharmacologic profiles relative to each other and to sumatriptan. As therapeutic options multiply, clinicians must be able to distinguish among these compounds. Recently, a meta-analysis was conducted on data from 53 double-blind, randomized,...

journal_title：Headache

authors： Ferrari MD

更新日期：2002-01-01 00:00:00

abstract：OBJECTIVE:To study the therapeutic potential of the subcutaneous administration of Nalpha-methylhistamine in migraine prophylaxis. BACKGROUND:The histamine catabolite, Nalpha-methylhistamine, possesses a selective affinity for H3 receptors. We consequently considered it viable to conduct a clinical pharmacological stu...

journal_title：Headache

authors： Millán-Guerrero RO,Pineda-Lucatero AG,Hernández-Benjamín T,Tene CE,Pacheco MF

更新日期：2003-04-01 00:00:00